| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 1.59e-05 | 2 | 80 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 1.59e-05 | 2 | 80 | 2 | GO:0003920 | |
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 SNED1 EYS SCUBE1 PLA2G2D ACAN SCUBE3 MATN4 EGFLAM LTBP3 EGFL8 LRP8 | 4.12e-05 | 749 | 80 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.08e-04 | 188 | 80 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | syndecan binding | 5.60e-04 | 9 | 80 | 2 | GO:0045545 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.24e-04 | 268 | 80 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.12e-03 | 51 | 80 | 3 | GO:0043394 | |
| GeneOntologyBiologicalProcess | IMP biosynthetic process | 2.47e-05 | 15 | 80 | 3 | GO:0006188 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide salvage | 3.03e-05 | 16 | 80 | 3 | GO:0106380 | |
| GeneOntologyBiologicalProcess | purine nucleotide salvage | 5.21e-05 | 19 | 80 | 3 | GO:0032261 | |
| GeneOntologyBiologicalProcess | purine-containing compound salvage | 8.20e-05 | 22 | 80 | 3 | GO:0043101 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate biosynthetic process | 9.41e-05 | 23 | 80 | 3 | GO:0009168 | |
| GeneOntologyBiologicalProcess | IMP metabolic process | 1.07e-04 | 24 | 80 | 3 | GO:0046040 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 1.22e-04 | 25 | 80 | 3 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 1.22e-04 | 25 | 80 | 3 | GO:0050962 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate biosynthetic process | 1.22e-04 | 25 | 80 | 3 | GO:0009127 | |
| GeneOntologyBiologicalProcess | nucleotide salvage | 1.37e-04 | 26 | 80 | 3 | GO:0043173 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 EYS FCGBP ZAN ADAMTS6 TNC ACAN MATN4 EGFLAM LTBP3 RTBDN MUC2 SSPOP OTOG IMPG2 | 2.87e-08 | 656 | 81 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 EYS FCGBP ZAN ADAMTS6 TNC ACAN MATN4 EGFLAM LTBP3 RTBDN MUC2 SSPOP OTOG IMPG2 | 2.99e-08 | 658 | 81 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.11e-06 | 6 | 81 | 3 | GO:0033165 | |
| GeneOntologyCellularComponent | GMP reductase complex | 1.48e-05 | 2 | 81 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.77e-05 | 530 | 81 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 7.97e-04 | 11 | 81 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.13e-03 | 13 | 81 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | interstitial matrix | 1.94e-03 | 17 | 81 | 2 | GO:0005614 | |
| Domain | EGF_3 | JAG2 SNED1 EYS SCUBE1 NTNG2 ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 SSPOP MEGF11 OTOG IMPG2 LRP8 | 4.52e-18 | 235 | 79 | 18 | PS50026 |
| Domain | EGF-like_dom | JAG2 SNED1 EYS SCUBE1 NTNG2 FCGBP ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 MEGF11 OTOG IMPG2 LRP8 | 1.27e-17 | 249 | 79 | 18 | IPR000742 |
| Domain | EGF_1 | JAG2 SNED1 EYS SCUBE1 NTNG2 ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 SSPOP ITGB7 MEGF11 IMPG2 LRP8 | 1.95e-17 | 255 | 79 | 18 | PS00022 |
| Domain | EGF_2 | JAG2 SNED1 EYS SCUBE1 NTNG2 ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 SSPOP ITGB7 MEGF11 IMPG2 LRP8 | 3.87e-17 | 265 | 79 | 18 | PS01186 |
| Domain | EGF | JAG2 RSPO3 SNED1 EYS SCUBE1 NTNG2 FCGBP ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 MEGF11 LRP8 | 1.11e-16 | 235 | 79 | 17 | SM00181 |
| Domain | EGF-like_CS | JAG2 SNED1 EYS SCUBE1 NTNG2 ZAN TNC SCUBE3 ADAM33 MATN4 EGFLAM LTBP3 EGFL8 ITGB7 MEGF11 IMPG2 LRP8 | 6.46e-16 | 261 | 79 | 17 | IPR013032 |
| Domain | EGF | 5.18e-12 | 126 | 79 | 11 | PF00008 | |
| Domain | Growth_fac_rcpt_ | JAG2 RSPO3 EYS ERBB4 SCUBE1 TNC INSRR SCUBE3 MATN4 LTBP3 LRP8 | 5.37e-11 | 156 | 79 | 11 | IPR009030 |
| Domain | EGF_CA | 9.59e-11 | 122 | 79 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.13e-10 | 124 | 79 | 10 | IPR001881 | |
| Domain | VWC_out | 1.23e-10 | 19 | 79 | 6 | SM00215 | |
| Domain | ASX_HYDROXYL | 3.78e-10 | 100 | 79 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.40e-10 | 106 | 79 | 9 | IPR000152 | |
| Domain | TIL | 9.21e-10 | 12 | 79 | 5 | PF01826 | |
| Domain | C8 | 9.21e-10 | 12 | 79 | 5 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.49e-09 | 13 | 79 | 5 | IPR014853 | |
| Domain | C8 | 1.49e-09 | 13 | 79 | 5 | SM00832 | |
| Domain | TIL_dom | 2.31e-09 | 14 | 79 | 5 | IPR002919 | |
| Domain | VWD | 5.01e-09 | 16 | 79 | 5 | SM00216 | |
| Domain | VWF_type-D | 5.01e-09 | 16 | 79 | 5 | IPR001846 | |
| Domain | VWFD | 5.01e-09 | 16 | 79 | 5 | PS51233 | |
| Domain | VWD | 5.01e-09 | 16 | 79 | 5 | PF00094 | |
| Domain | EGF_Ca-bd_CS | 7.61e-09 | 97 | 79 | 8 | IPR018097 | |
| Domain | EGF_CA | 8.95e-09 | 99 | 79 | 8 | PS01187 | |
| Domain | VWF_dom | 2.19e-08 | 42 | 79 | 6 | IPR001007 | |
| Domain | EGF_CA | 7.59e-08 | 86 | 79 | 7 | PF07645 | |
| Domain | hEGF | 1.08e-07 | 28 | 79 | 5 | PF12661 | |
| Domain | EGF_extracell | 1.97e-07 | 60 | 79 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.97e-07 | 60 | 79 | 6 | PF07974 | |
| Domain | TSP_1 | 2.65e-07 | 63 | 79 | 6 | PF00090 | |
| Domain | TSP1 | 3.20e-07 | 65 | 79 | 6 | SM00209 | |
| Domain | TSP1_rpt | 3.20e-07 | 65 | 79 | 6 | IPR000884 | |
| Domain | TSP1 | 3.20e-07 | 65 | 79 | 6 | PS50092 | |
| Domain | VWC | 5.36e-07 | 38 | 79 | 5 | SM00214 | |
| Domain | cEGF | 4.13e-06 | 26 | 79 | 4 | IPR026823 | |
| Domain | cEGF | 4.13e-06 | 26 | 79 | 4 | PF12662 | |
| Domain | VWFC_1 | 1.58e-05 | 36 | 79 | 4 | PS01208 | |
| Domain | GMPR | 1.77e-05 | 2 | 79 | 2 | IPR005993 | |
| Domain | VWFC_2 | 1.96e-05 | 38 | 79 | 4 | PS50184 | |
| Domain | EMI | 4.75e-05 | 17 | 79 | 3 | PS51041 | |
| Domain | TILa | 5.29e-05 | 3 | 79 | 2 | PF12714 | |
| Domain | TILa_dom | 5.29e-05 | 3 | 79 | 2 | IPR025615 | |
| Domain | Furin_repeat | 5.68e-05 | 18 | 79 | 3 | IPR006212 | |
| Domain | FU | 5.68e-05 | 18 | 79 | 3 | SM00261 | |
| Domain | IMPDH | 1.05e-04 | 4 | 79 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 1.05e-04 | 4 | 79 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 1.05e-04 | 4 | 79 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 1.05e-04 | 4 | 79 | 2 | IPR015875 | |
| Domain | Cys_knot_C | 1.57e-04 | 25 | 79 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.57e-04 | 25 | 79 | 3 | PS01225 | |
| Domain | MANSC_N | 1.75e-04 | 5 | 79 | 2 | IPR011106 | |
| Domain | MANEC | 1.75e-04 | 5 | 79 | 2 | SM00765 | |
| Domain | ArfGap | 2.46e-04 | 29 | 79 | 3 | SM00105 | |
| Domain | ArfGap | 2.46e-04 | 29 | 79 | 3 | PF01412 | |
| Domain | ARFGAP | 2.46e-04 | 29 | 79 | 3 | PS50115 | |
| Domain | ArfGAP | 2.46e-04 | 29 | 79 | 3 | IPR001164 | |
| Domain | MANSC_dom | 2.62e-04 | 6 | 79 | 2 | IPR013980 | |
| Domain | MANSC | 2.62e-04 | 6 | 79 | 2 | PS50986 | |
| Domain | Furin-like | 3.66e-04 | 7 | 79 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 3.66e-04 | 7 | 79 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 3.66e-04 | 7 | 79 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 3.66e-04 | 7 | 79 | 2 | PF01030 | |
| Domain | - | 3.66e-04 | 7 | 79 | 2 | 3.80.20.20 | |
| Domain | LDLR_class-A_CS | 6.43e-04 | 40 | 79 | 3 | IPR023415 | |
| Domain | PSI | 8.51e-04 | 44 | 79 | 3 | IPR016201 | |
| Domain | Ldl_recept_a | 9.09e-04 | 45 | 79 | 3 | PF00057 | |
| Domain | Fol_N | 9.48e-04 | 11 | 79 | 2 | IPR003645 | |
| Domain | Ephrin_rec_like | 9.48e-04 | 11 | 79 | 2 | PF07699 | |
| Domain | Laminin_G_1 | 9.48e-04 | 11 | 79 | 2 | PF00054 | |
| Domain | FOLN | 9.48e-04 | 11 | 79 | 2 | SM00274 | |
| Domain | PSI | 9.70e-04 | 46 | 79 | 3 | SM00423 | |
| Domain | - | 9.70e-04 | 46 | 79 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.10e-03 | 48 | 79 | 3 | PS01209 | |
| Domain | FN3 | 1.13e-03 | 185 | 79 | 5 | SM00060 | |
| Domain | EGF_3 | 1.13e-03 | 12 | 79 | 2 | PF12947 | |
| Domain | EGF_dom | 1.13e-03 | 12 | 79 | 2 | IPR024731 | |
| Domain | LDLRA_2 | 1.17e-03 | 49 | 79 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.17e-03 | 49 | 79 | 3 | IPR002172 | |
| Domain | LDLa | 1.17e-03 | 49 | 79 | 3 | SM00192 | |
| Domain | FN3_dom | 1.93e-03 | 209 | 79 | 5 | IPR003961 | |
| Domain | EMI_domain | 2.04e-03 | 16 | 79 | 2 | IPR011489 | |
| Domain | CTCK_1 | 2.59e-03 | 18 | 79 | 2 | PS01185 | |
| Domain | Semaphorin | 3.19e-03 | 20 | 79 | 2 | IPR027231 | |
| Domain | CT | 3.86e-03 | 22 | 79 | 2 | SM00041 | |
| Domain | - | 4.02e-03 | 248 | 79 | 5 | 1.25.40.20 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.91e-07 | 39 | 55 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.91e-07 | 39 | 55 | 5 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.96e-06 | 109 | 55 | 6 | MM15164 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.49e-06 | 68 | 55 | 5 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.89e-05 | 143 | 55 | 6 | M27275 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.08e-05 | 258 | 55 | 7 | MM14572 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.03e-05 | 111 | 55 | 5 | M27416 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.56e-04 | 300 | 55 | 7 | M610 | |
| Pathway | REACTOME_MET_RECEPTOR_ACTIVATION | 2.22e-04 | 6 | 55 | 2 | M27644 | |
| Pathway | REACTOME_MET_RECEPTOR_ACTIVATION | 2.22e-04 | 6 | 55 | 2 | MM15346 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.10e-04 | 250 | 55 | 6 | M27554 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.07e-04 | 47 | 55 | 3 | MM14925 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.13e-03 | 13 | 55 | 2 | MM15438 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.13e-03 | 13 | 55 | 2 | M814 | |
| Pubmed | 9.18e-07 | 75 | 81 | 5 | 20637190 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.01e-06 | 9 | 81 | 3 | 12640130 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.98e-06 | 11 | 81 | 3 | 15381706 | |
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 3.78e-06 | 45 | 81 | 4 | 34248495 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.02e-06 | 101 | 81 | 5 | 23382219 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19432394 | ||
| Pubmed | Regulation of arachidonic acid availability for eicosanoid production. | 5.36e-06 | 2 | 81 | 2 | 15052324 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15059978 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15234972 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34126068 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 218932 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28238185 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7524681 | ||
| Pubmed | Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. | 5.36e-06 | 2 | 81 | 2 | 29999571 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12009299 | ||
| Pubmed | Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry. | 1.60e-05 | 3 | 81 | 2 | 23533611 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31991528 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 20977675 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 1.60e-05 | 3 | 81 | 2 | 12270931 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 23300874 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 28604600 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 22691042 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 33368532 | ||
| Pubmed | Cbl-b deficiency prevents functional but not phenotypic T cell anergy. | 3.20e-05 | 4 | 81 | 2 | 33974042 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 24766640 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 26165838 | ||
| Pubmed | 3.82e-05 | 28 | 81 | 3 | 28218627 | ||
| Pubmed | 4.08e-05 | 709 | 81 | 9 | 22988430 | ||
| Pubmed | 5.22e-05 | 31 | 81 | 3 | 24014668 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 23383134 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 36301669 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 25313870 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 8817451 | ||
| Pubmed | Hepatocyte migration during liver development requires Prox1. | 7.99e-05 | 6 | 81 | 2 | 10888866 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 15162516 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 25639508 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 17336282 | ||
| Pubmed | Invariant Sema5A inhibition serves an ensheathing function during optic nerve development. | 1.49e-04 | 8 | 81 | 2 | 12506007 | |
| Pubmed | Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice. | 1.49e-04 | 8 | 81 | 2 | 11856531 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 15296947 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 8812066 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 15743826 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 10364163 | ||
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 1.91e-04 | 9 | 81 | 2 | 18570250 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 2.38e-04 | 10 | 81 | 2 | 20664521 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 16877353 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 26828067 | ||
| Pubmed | Human ALKBH4 interacts with proteins associated with transcription. | 2.38e-04 | 10 | 81 | 2 | 23145062 | |
| Pubmed | An essential role in liver development for transcription factor XBP-1. | 2.38e-04 | 10 | 81 | 2 | 10652269 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 27909010 | ||
| Pubmed | Matrilin-3 is dispensable for mouse skeletal growth and development. | 2.91e-04 | 11 | 81 | 2 | 14749384 | |
| Pubmed | 3.09e-04 | 56 | 81 | 3 | 20706999 | ||
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 30146491 | ||
| Pubmed | The onecut transcription factor hepatocyte nuclear factor-6 controls B lymphopoiesis in fetal liver. | 3.48e-04 | 12 | 81 | 2 | 12874218 | |
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 3.48e-04 | 12 | 81 | 2 | 10090148 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 27713690 | ||
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 11239002 | ||
| Pubmed | 4.37e-04 | 63 | 81 | 3 | 17672918 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 4.53e-04 | 420 | 81 | 6 | 28065597 | |
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 15760903 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 22453919 | ||
| Pubmed | Differential gene expression during early murine yolk sac development. | 4.79e-04 | 14 | 81 | 2 | 8562047 | |
| Pubmed | 5.12e-04 | 430 | 81 | 6 | 32581705 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 31812516 | ||
| Pubmed | Shox2 function couples neural, muscular and skeletal development in the proximal forelimb. | 7.12e-04 | 17 | 81 | 2 | 21156168 | |
| Pubmed | Identification of novel SHOX target genes in the developing limb using a transgenic mouse model. | 7.12e-04 | 17 | 81 | 2 | 24887312 | |
| Pubmed | Disrupted tenogenesis in masseter as a potential cause of micrognathia. | 7.12e-04 | 17 | 81 | 2 | 36257937 | |
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 8.00e-04 | 18 | 81 | 2 | 23041440 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 8.00e-04 | 18 | 81 | 2 | 35503090 | |
| Pubmed | 8.00e-04 | 18 | 81 | 2 | 33308444 | ||
| Pubmed | 8.64e-04 | 181 | 81 | 4 | 37372979 | ||
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 15051154 | ||
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 9377118 | ||
| Pubmed | 9.78e-04 | 83 | 81 | 3 | 11114734 | ||
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 15979417 | ||
| Pubmed | Vascular endothelium plays a key role in directing pulmonary epithelial cell differentiation. | 9.91e-04 | 20 | 81 | 2 | 28838957 | |
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 11438667 | ||
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 21670299 | ||
| Pubmed | Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. | 1.09e-03 | 21 | 81 | 2 | 21835343 | |
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 30021842 | ||
| Pubmed | 1.20e-03 | 22 | 81 | 2 | 27527664 | ||
| Pubmed | 1.20e-03 | 22 | 81 | 2 | 33898448 | ||
| Pubmed | 1.24e-03 | 90 | 81 | 3 | 15033168 | ||
| Pubmed | Detection of genes regulated by Lmx1b during limb dorsalization. | 1.31e-03 | 23 | 81 | 2 | 22417325 | |
| Pubmed | Hierarchical organization of cortical and thalamic connectivity. | 1.43e-03 | 24 | 81 | 2 | 31666704 | |
| Pubmed | 1.49e-03 | 210 | 81 | 4 | 16537572 | ||
| Pubmed | Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death. | 1.68e-03 | 26 | 81 | 2 | 9745929 | |
| Pubmed | 1.77e-03 | 102 | 81 | 3 | 11214970 | ||
| Pubmed | 1.81e-03 | 27 | 81 | 2 | 25133637 | ||
| Pubmed | 1.95e-03 | 28 | 81 | 2 | 18617019 | ||
| Pubmed | Developmental gene expression profiling along the tonotopic axis of the mouse cochlea. | 1.95e-03 | 28 | 81 | 2 | 22808246 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.99e-03 | 560 | 81 | 6 | 21653829 | |
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 2.09e-03 | 29 | 81 | 2 | 12435358 | |
| Pubmed | 2.09e-03 | 29 | 81 | 2 | 21834987 | ||
| Pubmed | 2.09e-03 | 985 | 81 | 8 | 12975309 | ||
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.48e-05 | 17 | 52 | 3 | 1291 | |
| GeneFamily | ArfGAPs | 1.15e-04 | 33 | 52 | 3 | 395 | |
| GeneFamily | Ankyrin repeat domain containing | 6.42e-04 | 242 | 52 | 5 | 403 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.32e-04 | 15 | 52 | 2 | 529 | |
| GeneFamily | Fibronectin type III domain containing | 1.15e-03 | 160 | 52 | 4 | 555 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.49e-03 | 20 | 52 | 2 | 736 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 2.33e-03 | 25 | 52 | 2 | 74 | |
| GeneFamily | Phospholipases | 6.49e-03 | 42 | 52 | 2 | 467 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.17e-02 | 57 | 52 | 2 | 1179 | |
| GeneFamily | LIM domain containing | 1.25e-02 | 59 | 52 | 2 | 1218 | |
| GeneFamily | Proteases, serine | 1.42e-02 | 63 | 52 | 2 | 738 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.66e-02 | 718 | 52 | 6 | 28 | |
| Coexpression | NABA_MATRISOME | RSPO3 SNED1 HGF EYS SCUBE1 NTNG2 SEMA5B ADAMTS6 TNC ACAN SCUBE3 SEMA5A ADAM33 MATN4 EGFLAM LTBP3 EGFL8 MUC2 SSPOP MEGF11 OTOG IMPG2 | 3.62e-13 | 1026 | 81 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | RSPO3 SNED1 HGF SCUBE1 NTNG2 SEMA5B ADAMTS6 TNC ACAN SCUBE3 SEMA5A ADAM33 MATN4 EGFLAM LTBP3 EGFL8 MUC2 SSPOP MEGF11 OTOG IMPG2 | 2.39e-12 | 1008 | 81 | 21 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | RSPO3 SNED1 EYS NTNG2 TNC ACAN MATN4 EGFLAM LTBP3 SSPOP OTOG IMPG2 | 5.20e-11 | 275 | 81 | 12 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.15e-10 | 196 | 81 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | RSPO3 SNED1 NTNG2 TNC ACAN MATN4 EGFLAM LTBP3 SSPOP OTOG IMPG2 | 7.25e-10 | 270 | 81 | 11 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.96e-09 | 191 | 81 | 9 | MM17059 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGF SCUBE1 SEMA5B ADAMTS6 SCUBE3 SEMA5A ADAM33 EGFL8 MUC2 MEGF11 | 9.13e-05 | 738 | 81 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGF SCUBE1 SEMA5B ADAMTS6 SCUBE3 SEMA5A ADAM33 EGFL8 MUC2 MEGF11 | 1.05e-04 | 751 | 81 | 10 | M5885 |
| Coexpression | MARSON_FOXP3_TARGETS_STIMULATED_UP | 1.09e-04 | 30 | 81 | 3 | M3146 | |
| Coexpression | MARSON_FOXP3_TARGETS_STIMULATED_UP | 1.09e-04 | 30 | 81 | 3 | MM728 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | CCDC125 RSPO3 SNED1 SCUBE1 TES SEMA5B BHLHA9 SCUBE3 MATN4 EGFLAM THSD7B MEGF11 | 1.10e-04 | 1074 | 81 | 12 | M1941 |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-07 | 172 | 81 | 6 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.10e-07 | 175 | 81 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.37e-07 | 176 | 81 | 6 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.94e-07 | 178 | 81 | 6 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-06 | 183 | 81 | 6 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 187 | 81 | 6 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-06 | 188 | 81 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-06 | 190 | 81 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-06 | 190 | 81 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-06 | 190 | 81 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 193 | 81 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-06 | 197 | 81 | 6 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.71e-06 | 199 | 81 | 6 | bd7f03bef4660c347da5f16db34d91d563908448 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-06 | 148 | 81 | 5 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 171 | 81 | 5 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 171 | 81 | 5 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-05 | 172 | 81 | 5 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 174 | 81 | 5 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 176 | 81 | 5 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 176 | 81 | 5 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 176 | 81 | 5 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 176 | 81 | 5 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 177 | 81 | 5 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 179 | 81 | 5 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 180 | 81 | 5 | 3f0a692ad2823951e0ec23d0452f436c5f5c09c0 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 180 | 81 | 5 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 180 | 81 | 5 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 181 | 81 | 5 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 182 | 81 | 5 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 182 | 81 | 5 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-05 | 182 | 81 | 5 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 183 | 81 | 5 | f06c06c75aab55fa8c803665afaa399446aec5af | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 183 | 81 | 5 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 183 | 81 | 5 | c7fedb5b0c1f17b3391ce1c4a6bfca7615c359c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 183 | 81 | 5 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 183 | 81 | 5 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 184 | 81 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 185 | 81 | 5 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 185 | 81 | 5 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 185 | 81 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 185 | 81 | 5 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 185 | 81 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 185 | 81 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 2.21e-05 | 185 | 81 | 5 | 481e3d3b63f2e5b4783088523c3cf70a461aed27 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 186 | 81 | 5 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 186 | 81 | 5 | ed265e52e4f9b6d277b489091ecc2e629436f791 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 187 | 81 | 5 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 187 | 81 | 5 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 188 | 81 | 5 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-05 | 188 | 81 | 5 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.39e-05 | 188 | 81 | 5 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 189 | 81 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.45e-05 | 189 | 81 | 5 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 190 | 81 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 190 | 81 | 5 | af39d2a46d9502cec69a69b7e8ffef78fc8311c3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 190 | 81 | 5 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 190 | 81 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 190 | 81 | 5 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 190 | 81 | 5 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.58e-05 | 191 | 81 | 5 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-05 | 191 | 81 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 192 | 81 | 5 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 192 | 81 | 5 | 71863f18a82394ed9f8e5ec8a4017215382a8284 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 192 | 81 | 5 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | ASK452-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.65e-05 | 192 | 81 | 5 | f04ee5aaa54c39b7493098fb3d2f78168d6b8060 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 192 | 81 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 193 | 81 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-05 | 193 | 81 | 5 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | d8e6a7f1da4506acaa06380b4aec3fe299ec8b7e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 193 | 81 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 193 | 81 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 194 | 81 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 194 | 81 | 5 | da88e8c11e55df296d2533f1d1575779cdf3edd7 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 194 | 81 | 5 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-05 | 195 | 81 | 5 | 441345d33f839a9e9222e790752b5603ff572bf2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-05 | 195 | 81 | 5 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | e4e362dca57adba90a2be38dce810857baa2f265 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.07e-05 | 198 | 81 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | 22c412a8d370fabfe4ccfad0b4c24fc965b88b74 | |
| Drug | 2-methylcarbazole | 1.22e-05 | 2 | 80 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 1.22e-05 | 2 | 80 | 2 | CID000165122 | |
| Drug | 3-nitrofluoranthen-6-ol | 1.22e-05 | 2 | 80 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 1.22e-05 | 2 | 80 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 1.22e-05 | 2 | 80 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 1.22e-05 | 2 | 80 | 2 | CID000053229 | |
| Drug | 2-nitrobenzofuran | 1.22e-05 | 2 | 80 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 1.22e-05 | 2 | 80 | 2 | CID000034321 | |
| Drug | AC1L25J4 | 1.22e-05 | 2 | 80 | 2 | CID000041328 | |
| Drug | thiopurinol | 1.48e-05 | 14 | 80 | 3 | CID000667510 | |
| Drug | 1,3-dinitropyrene | 1.84e-05 | 15 | 80 | 3 | CID000053230 | |
| Drug | 2-py | 1.84e-05 | 15 | 80 | 3 | CID010126464 | |
| Drug | 1,6-dinitropyrene | 4.56e-05 | 20 | 80 | 3 | CID000039184 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 6.31e-05 | 194 | 80 | 6 | 4552_UP | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 4081_UP | |
| Drug | anilino acetate | 7.28e-05 | 4 | 80 | 2 | CID000153367 | |
| Drug | c0458 | 7.28e-05 | 4 | 80 | 2 | CID009543178 | |
| Drug | nitromethanamine | 7.28e-05 | 4 | 80 | 2 | CID000061148 | |
| Drug | 1-amino-8-nitropyrene | 7.28e-05 | 4 | 80 | 2 | CID000108113 | |
| Drug | methyl p-nitrobenzoate | 7.28e-05 | 4 | 80 | 2 | CID000012083 | |
| Drug | chondroitin sulfate | 1.02e-04 | 413 | 80 | 8 | CID000024766 | |
| Drug | AC1LARMV | 1.02e-04 | 26 | 80 | 3 | CID000493817 | |
| Drug | 16alpha-hydroxyestrone | 1.15e-04 | 27 | 80 | 3 | CID000114852 | |
| Drug | nitroquinoline | 1.21e-04 | 5 | 80 | 2 | CID000025551 | |
| Drug | musk tibetene | 1.21e-04 | 5 | 80 | 2 | CID000067350 | |
| Drug | 2-hydroxylamino-4-nitrotoluene | 1.21e-04 | 5 | 80 | 2 | CID005488156 | |
| Drug | 4-nitrohippuric acid | 1.21e-04 | 5 | 80 | 2 | CID000017549 | |
| Drug | dimetridazole | 1.21e-04 | 5 | 80 | 2 | CID000003090 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 7.04e-05 | 5 | 79 | 2 | DOID:3030 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.98e-04 | 447 | 79 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | health-related quality of life measurement | 2.52e-04 | 9 | 79 | 2 | EFO_0011014 | |
| Disease | cerebral palsy (implicated_via_orthology) | 3.14e-04 | 10 | 79 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | blood copper measurement | 3.31e-04 | 50 | 79 | 3 | EFO_0007578 | |
| Disease | stenosing tenosynovitis | 4.59e-04 | 12 | 79 | 2 | EFO_0010822 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 5.42e-04 | 13 | 79 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | homostachydrine measurement | 5.42e-04 | 13 | 79 | 2 | EFO_0021164 | |
| Disease | hypoxanthine mesurement | 6.31e-04 | 14 | 79 | 2 | EFO_0010500 | |
| Disease | sexual dimorphism measurement | 7.26e-04 | 1106 | 79 | 10 | EFO_0021796 | |
| Disease | response to peritoneal dialysis, peritoneal solute transfer rate | 7.27e-04 | 15 | 79 | 2 | EFO_0600089, EFO_0600090 | |
| Disease | cortical surface area measurement | 8.89e-04 | 1345 | 79 | 11 | EFO_0010736 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 1.18e-03 | 19 | 79 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 1.30e-03 | 20 | 79 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | Osteoarthritis of hip | 1.30e-03 | 20 | 79 | 2 | C0029410 | |
| Disease | Nonsyndromic Deafness | 1.36e-03 | 81 | 79 | 3 | C3711374 | |
| Disease | longitudinal BMI measurement | 1.40e-03 | 82 | 79 | 3 | EFO_0005937 | |
| Disease | Giant Cell Glioblastoma | 1.51e-03 | 84 | 79 | 3 | C0334588 | |
| Disease | FEV/FEC ratio | RSPO3 FCGBP CLCN4 ACAN BHLHA9 SCUBE3 ADAM33 ZFHX3 LTBP3 AGAP3 | 1.60e-03 | 1228 | 79 | 10 | EFO_0004713 |
| Disease | body composition measurement | 1.82e-03 | 193 | 79 | 4 | EFO_0005106 | |
| Disease | stomach carcinoma (is_marker_for) | 1.88e-03 | 24 | 79 | 2 | DOID:5517 (is_marker_for) | |
| Disease | body weight | 1.94e-03 | 1261 | 79 | 10 | EFO_0004338 | |
| Disease | osteoarthritis, hip | 1.95e-03 | 92 | 79 | 3 | EFO_1000786 | |
| Disease | colorectal health | 2.11e-03 | 201 | 79 | 4 | EFO_0008460 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DILIQHGCPGEGCGL | 836 | Q96P47 | |
| HRECAGGCSGPKDTD | 231 | Q15303 | |
| EREGTGHGGPKLCCT | 146 | O43822 | |
| FTCGCPHDLVLGVDG | 166 | Q99944 | |
| PLGFEGLHCQKECGN | 811 | Q63HQ2 | |
| EGDGCTALHLACRKG | 666 | Q5VTM2 | |
| CGHLECHGPAARGDT | 131 | Q7RTU4 | |
| GHFLPCAGRDALCGK | 561 | Q9BZ11 | |
| LGKEGPLVHVACCCG | 221 | P51793 | |
| KGCGAFCHDDCIGPS | 1411 | Q76L83 | |
| GECKHVGCDNILGSD | 686 | Q9UKP5 | |
| GKDPLEGQRHCCGVA | 111 | O00170 | |
| ACPDKGIVLCGDEEG | 561 | Q9UFC0 | |
| RCEELCAPGTHGKGC | 171 | A6BM72 | |
| GKLHCPADVCGPLFE | 121 | Q96PR1 | |
| SRLCGKDQCAEGGHG | 211 | O95460 | |
| CGVTFHGICQDKGPA | 461 | Q5T1H1 | |
| PCHSGGLCEDLADGF | 506 | Q9Y219 | |
| DGCGCPDHTFLDEKG | 696 | Q02817 | |
| GPHHVCELCNKGTGE | 416 | P56270 | |
| DLGIATVPKGHCASC | 141 | O60711 | |
| GLKGHIISDGGCSCP | 211 | Q9P2T1 | |
| EICAGAEKIGSGPCE | 656 | P14210 | |
| SVLGECLDHFGPGCV | 286 | Q9NVV4 | |
| GLHVGLCSGPCEMAE | 76 | P49916 | |
| EPCGAGTCKETEGHV | 2286 | P16112 | |
| ISPEGGLCSGHGRCK | 606 | P26010 | |
| RAHQGSKPGCVGLCA | 76 | Q9H0J9 | |
| LPHTAVCLVCGEAGK | 656 | Q8NHM5 | |
| LELAVLGACLCHGPG | 271 | Q86Z20 | |
| GGILSCVTKDPCHGV | 4036 | Q9Y6R7 | |
| VGKGECHNIPCEKGD | 356 | Q6K0P9 | |
| LNECAKPHLCGDGGF | 661 | Q9NS15 | |
| KLGEECADVCPGVLG | 171 | P14616 | |
| HCPDRALCGGDGAAA | 91 | Q17RN3 | |
| GLKGHIISDGGCTCP | 211 | P36959 | |
| CKAGAHGVGDPAAAV | 126 | Q96DZ5 | |
| HGCLLDLGTCQAEPG | 91 | Q5W0N0 | |
| LVTGGDCGLGHALCK | 86 | P37059 | |
| HGCAHICRETPKGGV | 171 | Q8IWY4 | |
| HGCAHICRETPKGGI | 166 | Q8IX30 | |
| ACGEGAADIIIGHLC | 471 | P02771 | |
| GGADEAGCATLCAPH | 156 | Q14114 | |
| PLSAFHGVKGCLECD | 11 | Q5VZ72 | |
| SKAQGHGLCGICDGD | 2241 | Q6ZRI0 | |
| HGLCGICDGDAANDL | 2246 | Q6ZRI0 | |
| EGAAGPKCDDCLPTH | 431 | Q96CW9 | |
| ADLGKGKLHLAGPCC | 46 | Q9BSG5 | |
| GAEEECRHGGVCAPA | 231 | Q9Y6A5 | |
| GLGHEQGFGAPCLKC | 11 | Q9UGI8 | |
| CGQHCGKPEDCGELG | 841 | A2VEC9 | |
| GKPEDCGELGSCVAG | 846 | A2VEC9 | |
| EGCFCPEGTLLHGGA | 1311 | A2VEC9 | |
| DGGHCEELVPACAEG | 1366 | A2VEC9 | |
| GHCCPKAAGIIHLGA | 96 | P30566 | |
| GDKEIGPDGDSCAVC | 266 | Q8TEB7 | |
| AHGFPCCGKGSVEVA | 6 | Q96LK8 | |
| EGCTPLHLACRKGDG | 151 | O60733 | |
| CLNDGKCDIMPGHGA | 1061 | Q9BZV3 | |
| CHCGLGGRGQPKDAT | 46 | Q9UNK4 | |
| LCEYDALPGIGHACG | 111 | Q8IYS1 | |
| ADAHSCDCGPGFKGR | 1326 | Q8TER0 | |
| GGDICLGLHTEEALC | 876 | Q13591 | |
| EGDGCTALHLACRKG | 621 | A6NIR3 | |
| NCGRGGHIAKDCKEP | 76 | P62633 | |
| GGACAGLKEDLGACL | 11 | Q86WW8 | |
| IAGGKAHCGPAELCE | 71 | P43403 | |
| HGDGPRICKLCGNAF | 191 | Q8N8Z8 | |
| PEALGGGDKLACGAC | 1471 | Q9C0A1 | |
| GQGHGAVFDCKCSPD | 511 | Q8WWQ0 | |
| GCVEASLCLAHFGGP | 16 | Q6NVU6 | |
| SDKGHCVDLPDTGLC | 386 | O43278 | |
| ADCGELKCPNGCSGH | 401 | P24821 | |
| EGGAHAEDCGTAPLK | 56 | Q86WS5 | |
| HLGKCLDNCPEGLEA | 121 | Q9BXY4 | |
| CGIDACFGLETPKLH | 791 | Q9BY07 | |
| CGGLDCLGPAIHIAN | 646 | Q9P283 | |
| CKGDSGGPLSCHIDG | 216 | Q7RTY5 | |
| HSCEGPKHGCFICGE | 436 | Q9H5U6 | |
| VHTGESPHVCGDCGK | 331 | Q3KQV3 | |
| GERPHGCGECGKAFS | 446 | Q3KQV3 | |
| LASEGICFPDHGKCG | 546 | Q9C0I4 | |
| ICFPDHGKCGLGHRI | 551 | Q9C0I4 | |
| QHAGSLCELGVGECP | 621 | Q15911 | |
| QCGCKDAHGGSIPLG | 2266 | Q9Y493 | |
| IHSGERPHECGECGK | 481 | Q68DI1 | |
| AGCLLKCSGHGHCDP | 911 | Q5VV43 |